Supernus Pharmaceuticals Inc.
SUPN | NASDAQ
$42.78
+$0.78 (+1.86%)
At close: Sep 21, 2026, 4:00 PM ET
$42.78
$0 (0.00%)
After-hours:
Sep 21, 2026, 7:30 PM ET
Market Data
Market Cap $2.48B
Enterprise Value $2.15B
Beta 0.56
Average Volume 808.98K
Shares Outstanding (Diluted) 58.07M
Shares Change YoY 2.52%
Institutional Ownership N/A
Exchange NASDAQ
ISIN US8684591089
Price Performance
Price Change 1M -6.1%
Price Change 3M -3.8%
Price Change 6M -14.5%
Price Change YTD -13.5%
Price Change 1Y -8.9%
Price Change 3Y 51.9%
Price Change 5Y 53.8%
1M CAGR (ann.) -10.2%
1Y CAGR (ann.) -7.3%
5Y CAGR (ann.) 9.7%
All-Time CAGR 15.5%
Valuation
PE Ratio -22.28
Forward PE 9.86
PEG Ratio 0.21
Forward PEG -0.30
PS Ratio 2.99
Forward PS 1.80
PB Ratio 2.41
P/FCF Ratio 132.16
P/Adj. FCF Ratio -63.33
P/OCF Ratio 125.82
EV/Sales 2.59
EV/EBIT -18.29
EV/EBITDA -135.56
EV/FCF 114.50
Earnings Yield -4.5%
FCF Yield 0.8%
Adj. FCF Yield -1.6%
Financial Health
Net Cash $361.32M
Total Debt $40.17M
Cash & Short-Term Investments $372.07M
Total Assets $1.43B
Current Ratio 2.08
Quick Ratio 1.84
Debt / Equity Ratio 0.04
Debt / EBITDA -2.53
Debt / FCF 2.14
OCF / Debt 0.50
Interest Coverage -48.30
Altman Z-Score 4.83
Piotroski F-Score 3
Margins & Profitability
Gross Profit Margin 88.1%
Operating Profit Margin -13.5%
EBITDA Margin -1.9%
Net Profit Margin -13.2%
FCF Margin 2.3%
Adj. FCF Margin -4.7%
SBC / Revenue 7.0%
SBC Impact (per share) -308.7%
Returns
Return on Assets -7.7%
Return on Equity -10.4%
Return on Invested Capital -9.1%
Return on Capital Employed -10.3%
Return on Tangible Assets -13.1%
Historical Growth (CAGR)
Revenue CAGR 3Y 9.4%
Revenue CAGR 5Y 7.8%
Revenue CAGR 10Y 16.9%
EPS CAGR 3Y -446.3%
EPS CAGR 5Y -255.8%
EPS CAGR 10Y -30.0%
FCF CAGR 3Y -36.1%
FCF CAGR 5Y -30.8%
FCF CAGR 10Y -4.0%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 14
EPS Growth Next 3Y 132.3%
Revenue Growth Next 3Y 30.3%
Earnings Date Nov 2, 2026
EPS Estimate (next Q) $0.61
EPS Growth Est (next Q) -39.1%
Revenue Est (next Q) $218.29M
Revenue Growth Est (next Q) 13.6%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $57.60
Price Target Upside 34.6%
Cash Flow
Operating Cash Flow $19.91M
Free Cash Flow $18.79M
Adj. Free Cash Flow $-39.21M
FCF Per Share $0.32
OCF Per Share $0.34
OCF/S Ratio 2.4%
Income Statement
Revenue $830.44M
Gross Profit $731.41M
Operating Income $-111.81M
EBITDA $-15.87M
Net Income $-109.89M
EPS (Diluted) -$1.92
Revenue / Employee $1.07M
Profit / Employee $-141.24K
Employees 778
Add to Watchlist
Select watchlists to add or remove SUPN